Escalier Biosciences

Escalier Biosciences Overview

  • Founded
  • 2016
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $19M
Latest Deal Amount
  • Investors
  • 3

Escalier Biosciences General Information


Developer of small molecule therapeutics designed to advance the treatment of autoimmune diseases. The company's therapeutics have high penetration in the dermal tissues that limit systemic drug activity, allowing maximal target engagement at the site of inflammation and mitigates the risks of the off-target activity and immune suppression effects, enabling patients to get both topical and oral RORγt inverse agonists.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Transistorweg 5J
  • 6534 AT Nijmegen
  • Netherlands

Escalier Biosciences Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Escalier Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 04-Apr-2018 $19M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 14-Mar-2017 00.00 00.00 Completed Startup

Escalier Biosciences Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Semma Therapeutics Formerly VC-backed Cambridge, MA 00000 000000&0 00000
0000000 Formerly VC-backed Leuven, Belgium 00 00000 000000&0 00000
000000000 Venture Capital-Backed New York, NY 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Gaithersburg, MD 0 00000 00000000000 00000
0000000 Venture Capital-Backed San Mateo, CA 00 000.00 00000 00000 000.00

Escalier Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Raju Mohan Ph.D Co-Founder, Chief Executive Officer & Board Member
John Nuss Ph.D Chief Scientific Officer
Christopher Krueger JD Co-Founder & Chief Business Officer
Allison Luo MD Chief Medical Officer
Esther Van Den Boom Chief Financial Officer

Escalier Biosciences Board Members (5)

Name Representing Role Since
Edward Van Wezel BioGeneration Ventures Board Member 000 0000
Marco Boorsma Ph.D Forbion Board Member 000 0000
Norman Selby Self Board Member 000 0000
Raju Mohan Ph.D Escalier Biosciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Somasundaram Subramaniam New Science Ventures Chairman 000 0000

Escalier Biosciences Investors (3)

To view Escalier Biosciences‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Forbion Venture Capital Minority 000 0000 000000 0
BioGeneration Ventures Venture Capital Minority 000 0000 000000 0
New Science Ventures Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial